From: Pancancer network analysis reveals key master regulators for cancer invasiveness
Cancer | Cancer type | Full name |
---|---|---|
LGG | Primary | Brain low grade glioma |
KIRC | Primary | Kidney renal cell carcinoma |
SKCM | Metastatic | Skin cutaneous melanoma |
STAD | Primary | Stomach adenocarcinoma |
COAD | Primary | Colon adenocarcinoma |
ACC | Primary | Adrenocortical carcinoma |
BLCA | Primary | Bladder urothelial cancer |
BRCA | Primary | Breast invasive carcinoma |
CESC | Primary | Cervical squamous cell carcinoma and endocervical adenocarcinoma |
CHOL | Primary | Cholangiocarcinoma |
ESCA | Primary | Esophageal carcinoma |
GBM | Primary | Glioblastoma multiforme |
HNSC | Primary | Head and neck squamous cell carcinoma |
KICH | Primary | Kidney chromophobe |
PAAD | Primary | Pancreatic adenocarcinoma |
THYM | Primary | Thymoma |
KIRP | Primary | Kidney renal papillary cell carcinoma |
LIHC | Primary | Liver hepatocellular carcinoma |
LUAD | Primary | Lung adenocarcinoma |
DLBC | Primary | Lymphoid neoplasm diffuse large b-cell lymphoma |
MESO | Primary | Mesothelioma |
OV | Primary | Ovarian cystadenocarcinoma |
PCPG | Primary | Pheochromocytoma and paraganglioma |
PRAD | Primary | Prostate adenocarcinoma |
READ | Primary | Rectum adenocarcinoma |
TGCT | Primary | Testicular germ cell tumors |
THCA | Primary | Thyroid carcinoma |
UCS | Primary | Uterine carcinosarcoma |
UVM | Primary | Uveal melanoma |
UCEC | Primary | Uterine corpus endometrial carcinoma |
LUSC | Primary | Lung squamous cell carcinoma |
SARC | Primary | Sarcoma |